The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.
Open accessAbstract
A cell line established from a patient with acute lymphoblastic leukemia was found to express IL-2 binding sites with a novel, intermediate affinity compared with the characteristic high-affinity IL-2-receptors and low-affinity IL-2 binding sites described previously. Clones were isolated from this cell line that displayed solely this new IL-2-binding protein, and were found to be unreactive with anti-Tac, the mAb that competes with IL-2 for binding. Moreover, these same cloned cells did not express mRNA detectable by hybridization with radiolabeled cDNA encoding the Tac protein. In contrast, the original cell line and similar clones expressed low levels of Tac mRNA and cell surface Tac antigen, both of which could be augmented by exposure to medium conditioned by adult T leukemia cell lines. Particularly noteworthy, induction of Tac antigen expression was paralleled by an increase in the number of high-affinity IL-2-R detectable. Since the expression of the Tac antigen protein by itself makes only for low-affinity IL-2 binding, these data prompted a reevaluation of the structural composition of high-affinity IL-2-R. Analysis of the IL-2-binding proteins expressed by leukemic cell lines lacking high-affinity receptors revealed only a single protein, larger than the Tac antigen protein (Mr = 75,000 vs. 55,000). In contrast, clones induced to express high-affinity receptors had clearly both of these IL-2-binding proteins. Moreover, when IL-2 binding to normal T cells was performed under conditions that favored the proportion of high-affinity receptors occupied, two distinct proteins identical to those already identified on the leukemic cells could be crosslinked covalently to radiolabeled IL-2. The interpretations derived from these varied, assembled data, point to two IL-2-binding proteins, both of which are required for high-affinity IL-2 binding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043
The differentiation and function of human T lymphocytes
Reinherz, E. L., & Schlossman, S. F. (1980) · Cell · doi:10.1016/0092-8674(80)90072-0 · Cited by 1,530
Uchiyama, T., Broder, S., & Waldmann, T. A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1393 · Cited by 1,329
Three-Dimensional Structure of an Antigen-Antibody Complex at 2.8 Å Resolution
Amit, A. G., Mariuzza, R. A., Phillips, S. E. V., & Poljak, R. J. (1986) · Science · doi:10.1126/science.2426778 · Cited by 1,182
T cell growth factor receptors. Quantitation, specificity, and biological relevance
Robb, R., Munck, A., & Smith, K. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.154.5.1455 · Cited by 1,061
Self-citationLeonard, W. J., Depper, J. M., Uchiyama, T., Smith, K. A., Waldmann, T. A., & Greene, W. C. (1982) · Nature · doi:10.1038/300267a0 · Cited by 864
Self-citationMolecular cloning and expression of cDNAs for the human interleukin-2 receptor
Leonard, W. J., Depper, J. M., Crabtree, G. R., Rudikoff, S., Pumphrey, J., Robb, R. J., Krönke, M., Svetlik, P. B., Peffer, N. J., Waldmann, T. A., et al. (1984) · Nature · doi:10.1038/311626a0 · Cited by 850
Robb, R. J., Greene, W. C., & Rusk, C. M. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1126 · Cited by 725
Molecular cloning of cDNA encoding human interleukin-2 receptor
Nikaido, T., Shimizu, A., Ishida, N., Sabe, H., Teshigawara, K., Maeda, M., Uchiyama, T., Yodoi, J., & Honjo, T. (1984) · Nature · doi:10.1038/311631a0 · Cited by 565
Self-citationSmith, K. A. (1984) · Annual Review of Immunology · doi:10.1146/annurev.iy.02.040184.001535 · Cited by 499
Self-citationMeuer, S. C., Hussey, R. E., Cantrell, D. A., Hodgdon, J. C., Schlossman, S. F., Smith, K. A., & Reinherz, E. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1509 · Cited by 495
Self-citationPilch, P. F., & Czech, M. P. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50770-5 · Cited by 423
Interleukin 2 regulates its own receptors.
Smith, K. A., & Cantrell, D. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.864 · Cited by 406
Self-citationJames, R., & Bradshaw, R. A. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.001355 · Cited by 381
Sood, A. K., Pereira, D., & Weissman, S. M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.1.616 · Cited by 363
Monoclonal cytolytic T-cell lines.
Baker, P. E., Gillis, S., & Smith, K. A. (1979) · The Journal of experimental medicine · doi:10.1084/jem.149.1.273 · Cited by 359
Self-citationUchiyama, T., Nelson, D. L., Fleisher, T. A., & Waldmann, T. A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1398 · Cited by 346
Interleukin-2 Induction of T-Cell G 1 Progression and c- myb Expression
Stern, J. B., & Smith, K. A. (1986) · Science · doi:10.1126/science.3523754 · Cited by 244
Self-citationInterleukin 2 receptor gene expression in normal human T lymphocytes.
Leonard, W. J., Krönke, M., Peffer, N. J., Depper, J. M., & Greene, W. C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6281 · Cited by 164
Analysis of T-Cell Receptor Gene Rearrangement and Expression in Human Natural Killer Clones
Ritz, J., Campen, T. J., Schmidt, R. E., Royer, H. D., Hercend, T., Hussey, R. E., & Reinherz, E. L. (1985) · Science · doi:10.1126/science.2409597 · Cited by 154
Reconstitution of functional receptor for human interleukin-2 in mouse cells
Hatakeyama, M., Minamoto, S., Uchiyama, T., Hardy, R. R., Yamada, G., & Taniguchi, T. (1985) · Nature · doi:10.1038/318467a0 · Cited by 149
Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
Teshigawara, K., Maeda, M., Nishino, K., Nikaido, T., Uchiyama, T., Tsudo, M., Wano, Y., & Yodoi, J. (1985) · PubMed · Cited by 108
Self-citationRegulation of T cell autocrine growth. T4+ cells become refractory to interleukin 2.
Gullberg, M. H., & Smith, K. A. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.2.270 · Cited by 92
Self-citationOKADA, M., Maeda, M., Tagaya, Y., et al. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3995 · Cited by 82
Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfection.
Sabe, H., Kondo, S., Shimizu, A., et al. (1984) · PubMed · Cited by 38
Cited by
Interleukin-2: Inception, Impact, and Implications
Smith, K. A. (1988) · Science · doi:10.1126/science.3131876 · Cited by 2,153
Self-citationInterleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Noguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,320
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,080
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Liao, W., Lin, J.-X., & Leonard, W. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.01.004 · Cited by 1,075
Metadata
- Authors
- Teshigawara, K., Wang, H. M., Kato, K., & Smith, K. A.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1987-01-01
- Volume
- 165
- Issue
- 1
- Pages
- 223-238
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2141410410
- Cited by
- 548
- References
- 26
- FWCI
- 54.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.